Your browser doesn't support javascript.
loading
International cancer seminars: a focus on kidney cancer.
Scelo, G; Hofmann, J N; Banks, R E; Bigot, P; Bhatt, R S; Cancel-Tassin, G; Chew, S K; Creighton, C J; Cussenot, O; Davis, I J; Escudier, B; Frayling, T M; Häggström, C; Hildebrandt, M A T; Holcatova, I; Johansson, M; Linehan, W M; McDermott, D F; Nathanson, K L; Ogawa, S; Perlman, E J; Purdue, M P; Stattin, P; Swanton, C; Vasudev, N S; Wu, X; Znaor, A; Brennan, P; Chanock, S J.
Affiliation
  • Scelo G; Section of Genetics, International Agency for Research on Cancer, Lyon, France.
  • Hofmann JN; Division of Cancer Epidemiology and Genetics, Department of Health and Human Service, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  • Banks RE; Clinical and Biomedical Proteomics Group, Cancer Research UK Centre, Leeds Institute for Cancer Studies and Pathology, St James' University Hospital, Leeds, UK.
  • Bigot P; Department of Urology, Centre Hospitalier Universitaire d'Angers, Angers, France.
  • Bhatt RS; Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Kidney Cancer Program, Dana-Farber/Harvard Cancer Center, Boston, MA, USA.
  • Cancel-Tassin G; Groupe de Recherche GRC-UPMC n°5, Centre de Recherche sur les Pathologies Prostatiques et Urologiques (CeRePP), Paris, France.
  • Chew SK; Translational Cancer Therapeutics Laboratory, UCL Cancer Institute, University College London, London, UK.
  • Creighton CJ; Duncan Cancer Center-Biostatistics, Baylor College of Medicine, Houston.
  • Cussenot O; Groupe de Recherche GRC-UPMC n°5, Centre de Recherche sur les Pathologies Prostatiques et Urologiques (CeRePP), Paris, France.
  • Davis IJ; Department of Genetics, UNC School of Medicine, Chapel Hill, USA.
  • Escudier B; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
  • Frayling TM; University of Exeter Medical School, Exeter, UK.
  • Häggström C; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå Department of Biobank Research, Umeå University, Umeå, Sweden.
  • Hildebrandt MA; Department of Epidemiology, Division of OVP, Cancer Prevention and Population Sciences, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Holcatova I; Institute of Public Health and Preventive Medicine, Charles University, 2nd Faculty of Medicine, Prague, Czech Republic.
  • Johansson M; Section of Genetics, International Agency for Research on Cancer, Lyon, France.
  • Linehan WM; Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda.
  • McDermott DF; Division of Hematology/Oncology, Beth Israel Deaconess Medical Center, Kidney Cancer Program, Dana-Farber/Harvard Cancer Center, Boston, MA, USA.
  • Nathanson KL; Department of Medicine, University of Pennsylvania, Philadelphia, USA.
  • Ogawa S; Graduate School of Medicine, University of Tokyo, Tokyo, Japan.
  • Perlman EJ; Department of Pathology, Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, USA.
  • Purdue MP; Division of Cancer Epidemiology and Genetics, Department of Health and Human Service, National Cancer Institute, National Institutes of Health, Bethesda, USA.
  • Stattin P; Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, Umeå
  • Swanton C; University College London Hospitals and Cancer Institute, London, UK.
  • Vasudev NS; Clinical and Biomedical Proteomics Group, Cancer Research UK Centre, Leeds Institute for Cancer Studies and Pathology, St James' University Hospital, Leeds, UK.
  • Wu X; Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, USA.
  • Znaor A; Section of Genetics, International Agency for Research on Cancer, Lyon, France.
  • Brennan P; Section of Genetics, International Agency for Research on Cancer, Lyon, France brennanp@iarc.fr.
  • Chanock SJ; Division of Cancer Epidemiology and Genetics, Department of Health and Human Service, National Cancer Institute, National Institutes of Health, Bethesda, USA brennanp@iarc.fr.
Ann Oncol ; 27(8): 1382-5, 2016 08.
Article de En | MEDLINE | ID: mdl-27130845
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Génomique / Tumeurs du rein Type d'étude: Etiology_studies Limites: Humans Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2016 Type de document: Article Pays d'affiliation: France Pays de publication: Royaume-Uni
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Génomique / Tumeurs du rein Type d'étude: Etiology_studies Limites: Humans Langue: En Journal: Ann Oncol Sujet du journal: NEOPLASIAS Année: 2016 Type de document: Article Pays d'affiliation: France Pays de publication: Royaume-Uni